➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Medtronic
Colorcon
Boehringer Ingelheim
Harvard Business School

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 4,681,752

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,681,752
Title: Capsules containing the active principle of an allergen, and process for their preparation
Abstract:Capsules to be administered through an inhaler, or inhaler tube or nasal spray, containing a finely subdivided powder mixture of the active principle of one or more allergens, uniformly dispersed and incorporated into at least an excipient are described. The capsules have no bronchoconstrictive or irritating action on the nasal mucous membrane and are more effective than allergens administered in solution. The method of preparation is also described.
Inventor(s): Melillo; Gaetano (Naples, IT)
Assignee: Laboratorio Farmaceutico Lafarma S.a.S. (Milan, IT)
Application Number:06/597,241
Patent Claims:see list of patent claims

Details for Patent 4,681,752

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Greer Laboratories, Inc. STANDARDIZED MITE DERMATOPHAGOIDES FARINAE dermatophagoides farinae CONCENTRATE 101834 1 2010-02-03   Start Trial Laboratorio Farmaceutico Lafarma S.a.S. (Milan, IT) 2004-07-21 search
Greer Laboratories, Inc. STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS dermatophagoides pteronyssinus CONCENTRATE 101835 1 2010-02-03   Start Trial Laboratorio Farmaceutico Lafarma S.a.S. (Milan, IT) 2004-07-21 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
AstraZeneca
Express Scripts
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.